Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	73.76	37	135.7	81.35	186.82	220.38
Short-Term Investments	64.1	19.94	-	44.48	3.92	23.13
Cash & Short-Term Investments	137.86	56.94	135.7	125.83	190.73	243.51
Cash Growth	22.28%	-58.04%	7.85%	-34.03%	-21.67%	106.96%
Restricted Cash	0.11	0.11	0.07	0.12	0.16	0.56
Other Current Assets	5.23	5.09	5.31	7.6	13.53	5.94
Total Current Assets	143.21	62.14	141.08	133.55	204.42	250.02
Property, Plant & Equipment	6.86	7.33	9.82	12.51	14.97	14.91
Long-Term Investments	-	-	-	-	15.11	-
Other Long-Term Assets	0.63	0.63	0.63	0.63	0.87	0.38
Total Assets	150.7	70.09	151.53	146.69	235.37	265.3
Accounts Payable	4.46	2.57	2.52	4.74	3.02	3.31
Accrued Expenses	11	15.56	16.84	16.04	25.39	16.56
Current Portion of Leases	3.49	3.46	3.24	3.14	2.91	2.51
Current Unearned Revenue	-	0.15	1.31	9.21	7.64	7.89
Total Current Liabilities	18.95	21.74	23.91	33.13	38.96	30.27
Long-Term Leases	4.39	4.92	7.9	9.43	11.55	10.5
Long-Term Unearned Revenue	-	-	-	0.23	-	4.11
Other Long-Term Liabilities	10.92	72.41	27.64	-	0.13	0.38
Total Liabilities	34.25	99.07	59.45	42.79	50.64	45.26
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	690.91	588.58	578.33	502.61	487.35	394.96
Retained Earnings	-574.92	-618.01	-486.8	-399.12	-303.07	-174.74
Comprehensive Income & Other	0.45	0.45	0.55	0.4	0.45	-0.19
Total Common Equity	116.45	-28.97	92.08	103.9	184.73	220.04
Shareholders' Equity	116.45	-28.97	92.08	103.9	184.73	220.04
Total Liabilities & Equity	150.7	70.09	151.53	146.69	235.37	265.3
Total Debt	7.87	8.38	11.14	12.57	14.46	13.01
Net Cash (Debt)	129.99	48.56	124.57	113.25	176.28	230.51
Net Cash Growth	27.12%	-61.01%	9.99%	-35.75%	-23.52%	123.07%
Net Cash Per Share	19.10	7.75	48.59	66.31	110.57	576.95
Filing Date Shares Outstanding	6.11	6.11	3.03	1.72	1.71	1.53
Total Common Shares Outstanding	6.11	3.86	3	1.72	1.71	1.52
Working Capital	124.26	40.4	117.18	100.42	165.47	219.74
Book Value Per Share	19.04	-7.50	30.65	60.52	108.18	144.30
Tangible Book Value	116.45	-28.97	92.08	103.9	184.73	220.04
Tangible Book Value Per Share	19.04	-7.50	30.65	60.52	108.18	144.30
Machinery	8.09	8.04	7.91	8.28	7.48	6.23
Construction In Progress	0	0	0	0.02	0.02	0.07
Leasehold Improvements	6.1	6.1	6.1	6.09	5.94	5.66

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q